Can nebivolol be used to treat anxiety in an adult patient, particularly when they also have hypertension or tachycardia?

Nebivolol for Anxiety: Clinical Recommendation

Nebivolol is not recommended as a primary treatment for anxiety disorders, as there is no evidence supporting its effectiveness for this indication, and nonselective beta-blockers (not nebivolol) are the agents used when beta-blockade is considered for anxiety-related conditions. 1, 2

Evidence-Based Rationale

Beta-Blockers and Anxiety: The Selectivity Issue

The 2022 Hypertension guidelines explicitly state that nonselective beta-blockers are indicated for anxiety and other psychiatric disorders, while beta-blockers with higher beta-selectivity (like nebivolol) are indicated primarily for cardiovascular diseases. 1 This is a critical distinction because:

• Nebivolol is a highly cardioselective, third-generation beta-blocker 3
• The mechanism by which beta-blockers may help anxiety involves blocking peripheral beta-2 receptors that mediate physical symptoms (tremor, palpitations, sweating)
• Cardioselective agents like nebivolol preferentially block beta-1 receptors in the heart, not the beta-2 receptors responsible for peripheral anxiety symptoms

Specific Anxiety Conditions and Beta-Blocker Use

When beta-blockers are used for anxiety-related conditions, the evidence supports specific agents for specific indications:

• Panic disorder: Beta-blockers are commonly prescribed for symptom relief, typically combined with cognitive behavioral therapy and/or SSRIs and/or benzodiazepines, but no specific recommendation for nebivolol exists 1
• Performance anxiety: Beta-blockade is used, but again without specific evidence for nebivolol 1
• Post-traumatic stress disorder: Beta-blocker treatment may reduce consolidation of emotional memory when administered immediately after trauma, but this refers to nonselective agents 1

Recent Systematic Review Findings

A 2025 systematic review and meta-analysis specifically examining beta-blockers for anxiety disorders found no evidence for a beneficial effect of beta-blockers compared with either placebo or benzodiazepines in patients with social phobia or panic disorder (p ≥ 0.54 for all comparisons). 2 This review noted that beta-blocker prescriptions for anxiety increased substantially between 2003 and 2018 despite lack of supporting evidence. 2

FDA-Approved Indication

Nebivolol is FDA-approved solely for the treatment of hypertension, not for any psychiatric or anxiety-related indication. 4 The drug label makes no mention of anxiety as an indication or off-label use. 4

Clinical Context: When Nebivolol May Be Appropriate

Nebivolol should be considered when a patient has both hypertension (or another cardiovascular indication) AND anxiety, as it offers:

• Superior blood pressure control: Greater reductions in systolic BP (-11.0 mmHg), diastolic BP (-8.1 mmHg), and heart rate (-7.3 bpm) compared to other beta-blockers 5
• Cardiovascular outcomes benefit: 27% lower all-cause mortality (HR 0.73) and 19% lower major adverse cardiovascular events (HR 0.81) compared to other beta-blockers in hypertensive patients 5
• Favorable side-effect profile: Fewer side effects than traditional beta-blockers, including less sexual dysfunction, fatigue, and metabolic abnormalities 3
• Vasodilatory properties: Enhances nitric oxide bioavailability and functions as an antioxidant, which may improve endothelial function 3

Practical Algorithm

For a patient with anxiety:

1. Without hypertension/cardiovascular disease: Do not use nebivolol; consider SSRIs, SNRIs, or benzodiazepines as first-line 2
2. With hypertension requiring treatment: Nebivolol is an excellent choice for blood pressure control and cardiovascular outcomes, but do not expect it to treat the anxiety 5, 6
3. With performance anxiety or panic disorder requiring beta-blockade: Use a nonselective beta-blocker (propranolol is most studied) rather than nebivolol 1

Important Caveats

• Lack of clinical outcomes data for anxiety: While nebivolol has proven cardiovascular benefits, there are no studies demonstrating benefit for anxiety symptoms or anxiety-related clinical outcomes 7, 2
• Dosing considerations: Standard dosing for hypertension is 5 mg once daily, titrated up to 40 mg if needed 4
• Drug interactions: Use caution with CYP2D6 inhibitors (fluoxetine, paroxetine), which are commonly prescribed SSRIs for anxiety 4